Showing results (651-660 of 929) with videos related to
Sort By:
Pageof 93
BJU International|January 13, 2011
The role of haematuria in bladder cancer screening among men with former occupational exposure to aromatic aminesBeate Pesch, Michael Nasterlack, Friedhelm Eberle, et al.International Archives of Occupational and Environmental Health|October 17, 2013
Screening for bladder cancer with urinary tumor markers in chemical workers with exposure to aromatic aminesBeate Pesch, Dirk Taeger, Georg Johnen, et al.Journal of Toxicology and Environmental Health. Part A|June 13, 2012
Impact of different welding techniques on biological effect markers in exhaled breath condensate of 58 mild steel weldersFrank Hoffmeyer, Monika Raulf-Heimsoth, Martin Lehnert, et al.Archives of Toxicology|December 20, 2002
Association between head and neck cancer and microsomal epoxide hydrolase genotypesMatthias Wenghoefer, Beate Pesch, Volker Harth, et al.Human Molecular Genetics|December 20, 2002
Connexin30 (Gjb6)-deficiency causes severe hearing impairment and lack of endocochlear potentialBarbara Teubner, Vincent Michel, Jörg Pesch, et al.Breast Cancer Research and Treatment|June 4, 2008
CYP2C19*17 is associated with decreased breast cancer riskChristina Justenhoven, Ute Hamann, Christiane B Pierl, et al.Chronobiology International|September 18, 2014
Polymorphisms in circadian genes, night work and breast cancer: results from the GENICA studySylvia Rabstein, Volker Harth, Christina Justenhoven, et al.BMC Public Health|February 15, 2022
Smoking intensity and urinary nicotine metabolites by socioeconomic status in the Heinz Nixdorf Recall studyJan Hovanec, Tobias Weiß, Holger M Koch, et al.International Journal of Molecular Medicine|February 15, 2001
Complete form of X-linked congenital stationary night blindness: refined mapping and evidence of genetic homogeneityC M Pusch, J Maurer, J Ramser, et al.Breast Cancer Research and Treatment|July 17, 2010
Polymorphisms of the nuclear receptor pregnane X receptor and organic anion transporter polypeptides 1A2, 1B1, 1B3, and 2B1 are not associated with breast cancer riskChristina Justenhoven, Elke Schaeffeler, Stefan Winter, et al.Pageof 93